108 related articles for article (PubMed ID: 22877620)
1. Urinary leukotriene E4 as a biomarker of exposure, susceptibility and risk in asthma.
Rabinovitch N
Immunol Allergy Clin North Am; 2012 Aug; 32(3):433-45. PubMed ID: 22877620
[TBL] [Abstract][Full Text] [Related]
2. Urinary leukotriene E4.
Rabinovitch N
Immunol Allergy Clin North Am; 2007 Nov; 27(4):651-64; vii. PubMed ID: 17996582
[TBL] [Abstract][Full Text] [Related]
3. Urinary Leukotriene E
Hoffman BC; Rabinovitch N
Immunol Allergy Clin North Am; 2018 Nov; 38(4):599-610. PubMed ID: 30342582
[TBL] [Abstract][Full Text] [Related]
4. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
[TBL] [Abstract][Full Text] [Related]
5. [Urinary leukotrience E(4) level in children with asthma].
He MJ; Chen Q; Liu JM
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):909-12. PubMed ID: 20113659
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma.
Bizzintino JA; Khoo SK; Zhang G; Martin AC; Rueter K; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN; Hayden CM
Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):9-15. PubMed ID: 19524426
[TBL] [Abstract][Full Text] [Related]
7. Urinary leukotriene E₄ levels identify children with tobacco smoke exposure at risk for asthma exacerbation.
Rabinovitch N; Reisdorph N; Silveira L; Gelfand EW
J Allergy Clin Immunol; 2011 Aug; 128(2):323-7. PubMed ID: 21807251
[TBL] [Abstract][Full Text] [Related]
8. Urinary leukotriene LTE4 levels in non-responders to antileukotriene therapy.
Lee DK
Thorax; 2004 Aug; 59(8):727; author reply 727. PubMed ID: 15282399
[No Abstract] [Full Text] [Related]
9. Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease.
Field JJ; Strunk RC; Knight-Perry JE; Blinder MA; Townsend RR; DeBaun MR
Am J Hematol; 2009 Apr; 84(4):231-3. PubMed ID: 19291727
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
O'Byrne PM; Gauvreau GM; Murphy DM
J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
[TBL] [Abstract][Full Text] [Related]
11. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
12. Urinary leukotriene E4 and 9 alpha, 11 beta-prostaglandin F concentrations in mild, moderate and severe asthma, and in healthy subjects.
Misso NL; Aggarwal S; Phelps S; Beard R; Thompson PJ
Clin Exp Allergy; 2004 Apr; 34(4):624-31. PubMed ID: 15080817
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy.
Piedimonte G; Renzetti G; Auais A; Di Marco A; Tripodi S; Colistro F; Villani A; Di Ciommo V; Cutrera R
Pediatr Pulmonol; 2005 Oct; 40(4):285-91. PubMed ID: 16106356
[TBL] [Abstract][Full Text] [Related]
14. Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
Rabinovitch N; Zhang L; Gelfand EW
J Allergy Clin Immunol; 2006 Sep; 118(3):635-40. PubMed ID: 16950282
[TBL] [Abstract][Full Text] [Related]
15. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
[TBL] [Abstract][Full Text] [Related]
16. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
[TBL] [Abstract][Full Text] [Related]
17. Urinary cysteinyl leukotriene E4 level and therapeutic response to montelukast in children with mild obstructive sleep apnea.
Sunkonkit K; Sritippayawan S; Veeravikrom M; Deerojanawong J; Prapphal N
Asian Pac J Allergy Immunol; 2017 Dec; 35(4):233-238. PubMed ID: 28364411
[TBL] [Abstract][Full Text] [Related]
18. Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients.
Tug T; Godekmerdan A; Sari N; Karatas F; Erdem ES
Clin Pharmacol Ther; 2007 Mar; 81(3):371-6. PubMed ID: 17339866
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of response to asthma controller therapy: clinical implications.
Langmack EL; Martin RJ
Curr Opin Pulm Med; 2010 Jan; 16(1):13-8. PubMed ID: 19875959
[TBL] [Abstract][Full Text] [Related]
20. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
[No Abstract] [Full Text] [Related]
[Next] [New Search]
